Name: | CODAGENIX INC. |
Jurisdiction: | New York |
Legal type: | FOREIGN BUSINESS CORPORATION |
Status: | Active |
Date of registration: | 01 Apr 2009 (16 years ago) |
Entity Number: | 3793440 |
ZIP code: | 11735 |
County: | Nassau |
Place of Formation: | Delaware |
Address: | 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, United States, 11735 |
CAGE number | Status | Type | Established | CAGE Update Date | CAGE Expiration | SAM Expiration | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5D8K5 | Active | Non-Manufacturer | 2009-03-26 | 2024-09-16 | 2029-09-16 | 2025-09-12 | |||||||||||||
|
POC | JEFFREY FU |
Phone | +1 484-358-6843 |
Address | 3 BIOSCIENCE PARK DR BLDG II STE 501, FARMINGDALE, NASSAU, NY, 11735, UNITED STATES |
Ownership of Offeror Information
Highest Level Owner | Information not Available |
---|
Immediate Level Owner | Information not Available |
---|
List of Offerors (0) | Information not Available |
---|
Name | Role | Address |
---|---|---|
CODAGENIX INC. | DOS Process Agent | 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, United States, 11735 |
Name | Role | Address |
---|---|---|
JOHN ROBERT COLEMAN | Chief Executive Officer | 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, United States, 11735 |
Start date | End date | Type | Value |
---|---|---|---|
2023-04-06 | 2023-04-06 | Address | 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Chief Executive Officer) |
2021-04-27 | 2023-04-06 | Address | 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Service of Process) |
2020-11-16 | 2023-04-06 | Address | 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Chief Executive Officer) |
2020-01-07 | 2020-11-16 | Address | 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Principal Executive Office) |
2011-05-09 | 2020-01-07 | Address | 7 GAY DRIVE, GREAT NECK, NY, 11024, USA (Type of address: Principal Executive Office) |
2011-05-09 | 2020-11-16 | Address | 7 GAY DRIVE, GREAT NECK, NY, 11024, USA (Type of address: Chief Executive Officer) |
2009-04-01 | 2021-04-27 | Address | 5211 15TH AVE., BROOKLYN, NY, 11219, USA (Type of address: Service of Process) |
Filing Number | Date Filed | Type | Effective Date |
---|---|---|---|
230406000507 | 2023-04-06 | BIENNIAL STATEMENT | 2023-04-01 |
211220000851 | 2021-12-20 | BIENNIAL STATEMENT | 2021-12-20 |
210427000210 | 2021-04-27 | CERTIFICATE OF CHANGE | 2021-04-27 |
201116002020 | 2020-11-16 | AMENDMENT TO BIENNIAL STATEMENT | 2019-04-01 |
200107061151 | 2020-01-07 | BIENNIAL STATEMENT | 2019-04-01 |
130422002114 | 2013-04-22 | BIENNIAL STATEMENT | 2013-04-01 |
110509002356 | 2011-05-09 | BIENNIAL STATEMENT | 2011-04-01 |
090401000332 | 2009-04-01 | APPLICATION OF AUTHORITY | 2009-04-01 |
Contract Type | Award or IDV Flag | PIID | Start Date | Current End Date | Potential End Date | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DEFINITIVE CONTRACT | AWARD | 75A50123C00048 | 2023-09-30 | 2024-12-31 | 2026-07-31 | |||||||||||||||||||||||||
|
Obligated Amount | 10000000.00 |
Current Award Amount | 57630647.00 |
Potential Award Amount | 389449173.00 |
Description
Title | CONDUCT A PHASE 2B EFFICACY STUDY AS PRESCRIBED IN AOI15 WITH COVILIV A PROPRIETARY LIVE ATTENUATED VIRUS COVID-19 VACCINE. |
NAICS Code | 541714: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
Product and Service Codes | AN42: HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH |
Recipient Details
Recipient | CODAGENIX INC. |
UEI | TEMNL437K2F1 |
Recipient Address | UNITED STATES, 3 BIOSCIENCE PARK DR, FARMINGDALE, SUFFOLK, NEW YORK, 117351019 |
Date of last update: 17 Jan 2025
Sources: New York Secretary of State